These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
115 related articles for article (PubMed ID: 8984757)
1. [Risk of venous thromboembolism during postmenopausal hormone therapy]. Pedersen AT; Ottesen B Ugeskr Laeger; 1996 Nov; 158(48):6923-4. PubMed ID: 8984757 [No Abstract] [Full Text] [Related]
2. [Risk of venous thrombosis during postmenopausal estrogen therapy? The reporting system of adverse effects is functioning]. Buajordet I; Dybwad TB Tidsskr Nor Laegeforen; 1997 Aug; 117(18):2644-5. PubMed ID: 9324824 [No Abstract] [Full Text] [Related]
3. [Postmenopausal hormonal substitution and risk of venous thromboembolism. Need for prospective, randomized trials]. Arnesen H; Qvigstad E Tidsskr Nor Laegeforen; 1997 Nov; 117(28):4064. PubMed ID: 9441436 [No Abstract] [Full Text] [Related]
4. [Estrogens and cardiovascular diseases: should current guidelines be changed?]. Beller F; Theiss W Zentralbl Gynakol; 1994; 116(8):441-8. PubMed ID: 7941812 [TBL] [Abstract][Full Text] [Related]
5. [Risk of thromboembolism in contraception and hormone substitution: an update and recommendations]. van den Brûle F; Gaspard U J Pharm Belg; 2004; 59(1):38-40. PubMed ID: 15129579 [TBL] [Abstract][Full Text] [Related]
6. [Effects of hormone replacement treatment of menopause on the risk of venous thromboembolic disease]. Thery C; Prat A; Asseman P; Bauchart JJ; Michon P; Lesenne M; Jude B Therapie; 1997; 52(3):165-8. PubMed ID: 9366099 [TBL] [Abstract][Full Text] [Related]
7. [Risks and benefits of postmenopausal hormone replacement therapy]. Szántó F Orv Hetil; 1998 Nov; 139(44):2639-42. PubMed ID: 9842237 [TBL] [Abstract][Full Text] [Related]
8. [Postmenopausal hormone therapy and venous thrombosis]. Høibraaten E Tidsskr Nor Laegeforen; 1996 Feb; 116(5):653. PubMed ID: 8658462 [No Abstract] [Full Text] [Related]
9. Hormone therapy and venous thromboembolism among postmenopausal women: impact of the route of estrogen administration and progestogens: the ESTHER study. Canonico M; Oger E; Plu-Bureau G; Conard J; Meyer G; Lévesque H; Trillot N; Barrellier MT; Wahl D; Emmerich J; Scarabin PY; Circulation; 2007 Feb; 115(7):840-5. PubMed ID: 17309934 [TBL] [Abstract][Full Text] [Related]
11. Letter by Micheletti and Chevallier regarding article, "Hormone therapy and venous thromboembolism among postmenopausal women: impact of the route of estrogen administration and progestogens: the ESTHER Study". Micheletti MC; Chevallier T Circulation; 2007 Sep; 116(13):e362; author reply e363. PubMed ID: 17893283 [No Abstract] [Full Text] [Related]
12. Are some types of hormone therapy safer than others? Lessons from the Estrogen and Thromboembolism Risk study. Rexrode KM; Manson JE Circulation; 2007 Feb; 115(7):820-2. PubMed ID: 17309929 [No Abstract] [Full Text] [Related]
13. [The risk of venous thromboembolism in women during hormone replacement therapy]. Zeltzer D; Shapira I; Berliner S Harefuah; 1999 Aug; 137(3-4):124-6. PubMed ID: 10959301 [No Abstract] [Full Text] [Related]
14. Health risks after cessation of postmenopausal hormone therapy. Pines A; Sturdee D; Birkhäuser M; Climacteric; 2008 Jun; 11(3):179-80. PubMed ID: 18568782 [No Abstract] [Full Text] [Related]
15. [Hormone therapy and risk for venous thromboembolism in postmenopausal women]. Lacut K; Oger E Rev Prat; 2005 Feb; 55(4):389-92. PubMed ID: 15828617 [TBL] [Abstract][Full Text] [Related]